Media releases

R23 million Ergo plant upgrade to increase treatment capacity: feasibility study completed

DRDGOLD Limited has announced the completion of a feasibility study for a R23 million upgrade of its Ergo plant.

Johannesburg, South Africa. 10 February 2015. DRDGOLD Limited (DRDGOLD; JSE, NYSE: DRD) has announced the completion of a feasibility study for a R23 million upgrade of its Ergo plant to effect an increase in treatment capacity by 300 000 tonnes per month (tpm) to a total of 2.1 million tpm.

The feasibility study envisages refurbishment and re-commissioning of five tanks within the Ergo plant’s existing carbon in leach circuit, initially in order to treat the 21 million tonne Van Dyk tailings dam resource.

The project would be funded from additional internal cash flows from the retreatment of the Van Dyk dam and breaks even at a gold price of R384 000 per kilogram.

The project is expected to be completed by September 2015.

South Africa & North America

James Duncan, Russell and Associates
+27 11 880 3924 (office)
+27 (0) 79 336 4010 (mobile)

United Kingdom/Europe
Investor and Media Relations
Phil Dexter, St James’s Corporate Services
+44 (0) 20 7796 8644 (office)
+44 (0) 779 863 4398 (mobile)


Many factors could cause the actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, adverse changes or uncertainties in general economic conditions in the markets we serve, a drop in the gold price, a sustained strengthening of the Rand against the Dollar, regulatory developments adverse to DRDGOLD or difficulties in maintaining necessary licenses or other governmental approvals, changes in DRDGOLD’s competitive position, changes in business strategy, any major disruption in production at key facilities or adverse changes in foreign exchange rates and various other factors. These risks include, without limitation, those described in the section entitled “Risk Factors” included in our annual report for the fiscal year ended 30 June 2013, which we filed with the United States Securities and Exchange Commission on 25 October 2013 on Form 20-F. You should not place undue reliance on these forward-looking statements, which speak only as of the date thereof. We do not undertake any obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date of this report or to the occurrence of unanticipated events. Any forward-looking statement included in this report have not been reviewed and reported on by DRDGOLD’s auditors.

COOKIES: This site uses cookies to enhance your website experience. See our privacy policy for further details.